The collaboration leverages the scientific authority of the IDSA, which represents a global network of 13,000 clinicians and scientists, alongside the publishing infrastructure of Conexiant. By moving away from traditional static reporting, the platform intends to translate complex research and breaking developments into actionable clinical guidance. Charlie Lee, CEO of Conexiant, noted that the primary challenge for specialists is determining which information is authoritative and clinically relevant in a high-velocity environment.

Content will span major research updates, expert commentary, and coverage of industry events, starting with the upcoming IDWeek 2026 in Washington, D.C. Jeanne Marrazzo, CEO of the IDSA, emphasized that the initiative is designed to maintain a year-round connection between the research community and practitioners who rely on verified information to manage outbreaks and patient treatment. The platform is currently accessible via their dedicated website, with distribution channels including recurring newsletters and social media feeds.